PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
88.67%
Positive revenue growth while CVE is negative. John Neff might see a notable competitive edge here.
189.76%
Positive gross profit growth while CVE is negative. John Neff would see a clear operational edge over the competitor.
1037.82%
Positive EBIT growth while CVE is negative. John Neff might see a substantial edge in operational management.
1037.82%
Positive operating income growth while CVE is negative. John Neff might view this as a competitive edge in operations.
2541.03%
Positive net income growth while CVE is negative. John Neff might see a big relative performance advantage.
2595.00%
Positive EPS growth while CVE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
2595.00%
Positive diluted EPS growth while CVE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.18%
Share reduction while CVE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
-6.98%
Dividend reduction while CVE stands at 1.64%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-36.84%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-41.99%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-71.76%
Negative 10Y revenue/share CAGR while CVE stands at 43.02%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
29.57%
Positive 5Y CAGR while CVE is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
104.22%
3Y revenue/share CAGR above 1.5x CVE's 3.01%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-78.47%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-6.30%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
10.34%
3Y OCF/share CAGR above 1.5x CVE's 1.53%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-24.74%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
417.78%
Positive 5Y CAGR while CVE is negative. John Neff might view this as a strong mid-term relative advantage.
248.83%
Positive short-term CAGR while CVE is negative. John Neff would see a clear advantage in near-term profit trajectory.
-74.49%
Negative equity/share CAGR over 10 years while CVE stands at 11.11%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
12.04%
5Y equity/share CAGR 1.25-1.5x CVE's 8.04%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
6.79%
Positive short-term equity growth while CVE is negative. John Neff sees a strong advantage in near-term net worth buildup.
-96.59%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-74.19%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-70.52%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-35.11%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
0.17%
Positive asset growth while CVE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
14.88%
Positive BV/share change while CVE is negative. John Neff sees a clear edge over a competitor losing equity.
-0.12%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-24.18%
We cut SG&A while CVE invests at 11.54%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.